T-cell immunotherapy with a chimeric receptor against CD38 is effective in eradicating chemotherapy-resistant B-cell lymphoma cells overexpressing survivin induced by BMI-1

J. Bhattacharyya; K. Mihara; A. Kitanaka; K. Yanagihara; T. Kubo; Y. Takei; A. Kimura; Y. Takihara

doi:10.1038/bcj.2012.21

T-cell immunotherapy with a chimeric receptor against CD38 is effective in eradicating chemotherapy-resistant B-cell lymphoma cells overexpressing survivin induced by BMI-1

J. Bhattacharyya
, K. Mihara
, A. Kitanaka
, K. Yanagihara
, T. Kubo
, Y. Takei
, A. Kimura
, Y. Takihara

研究成果: ジャーナルへの寄稿 › Letter › 査読

本文言語	英語
論文番号	e75
ジャーナル	Blood cancer journal
巻	2
号	6
DOI	https://doi.org/10.1038/bcj.2012.21
出版ステータス	出版済み - 29-06-2012
外部発表	はい

All Science Journal Classification (ASJC) codes

血液学
腫瘍学

文献へのアクセス

10.1038/bcj.2012.21

他のファイルとリンク

引用スタイル

@article{778e1107b4b7459c9b93710798508cae,

title = "T-cell immunotherapy with a chimeric receptor against CD38 is effective in eradicating chemotherapy-resistant B-cell lymphoma cells overexpressing survivin induced by BMI-1",

author = "J. Bhattacharyya and K. Mihara and A. Kitanaka and K. Yanagihara and T. Kubo and Y. Takei and A. Kimura and Y. Takihara",

year = "2012",

month = jun,

day = "29",

doi = "10.1038/bcj.2012.21",

language = "English",

volume = "2",

journal = "Blood cancer journal",

issn = "2044-5385",

publisher = "Springer Nature",

number = "6",

}

TY - JOUR

T1 - T-cell immunotherapy with a chimeric receptor against CD38 is effective in eradicating chemotherapy-resistant B-cell lymphoma cells overexpressing survivin induced by BMI-1

AU - Bhattacharyya, J.

AU - Mihara, K.

AU - Kitanaka, A.

AU - Yanagihara, K.

AU - Kubo, T.

AU - Takei, Y.

AU - Kimura, A.

AU - Takihara, Y.

PY - 2012/6/29

Y1 - 2012/6/29

UR - https://www.scopus.com/pages/publications/84864048421

UR - https://www.scopus.com/pages/publications/84864048421#tab=citedBy

U2 - 10.1038/bcj.2012.21

DO - 10.1038/bcj.2012.21

M3 - Letter

C2 - 22829977

AN - SCOPUS:84864048421

SN - 2044-5385

VL - 2

JO - Blood cancer journal

JF - Blood cancer journal

IS - 6

M1 - e75

ER -